Researchers find that SARS-CoV-2 spike protein persists in the skull-meninges-brain axis, driving neuroinflammation, ...

Researchers from Helmholtz Munich and Ludwig-Maximilians-Universität (LMU) have identified a mechanism that may explain the ...

A new study reveals that the SARS-CoV-2 spike protein remains in brain-protective tissues and skull bone marrow for years after infection, potentially driving long COVID's neurological symptoms.

Researchers have identified that the SARS-CoV-2 spike protein accumulates in the brain's protective layers, potentially ...

Explore groundbreaking research linking SARS-CoV-2 spike protein accumulation to long-lasting brain effects in long COVID.

You may have encountered the term “bird flu” increasingly online and in the media. It refers to a highly pathogenic avian ...

What do Kash Patel, Mehmet Oz, and Mike Huckabee have in common? They're all poised to join the Trump administration despite ...

Sunflower Therapeutics (Sunflower), a public benefit corporation transforming global access to protein manufacturing capacity ...

Delve into the expanding and diverse field of cancer vaccines with various approaches exploiting the immune system to fight ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” third quarter ...

The poultry industry loses up to $6 billion annually due to necrotic enteritis, a preventable intestinal disease in poultry, ...

The State Institute for Drug Control (SICC) compares the effectiveness of mRNA vaccines with heroin, which was considered a ...